In clinical applications, peripheral blood detection has the advantages of repeatability and less trauma, so circulating CASC7 is expected to become an important marker for the diagnosis of HCC and the monitoring of disease progression. The gene discussed is AGO2; the disease is hepatocellular carcinoma.